Home
>
National Drug Code (NDC)
>
Equetro
Equetro - 30698-423-12 - (carbamazepine)
Drug Information of Equetro
| Product NDC: | 30698-423 |
| Proprietary Name: | Equetro |
| Non Proprietary Name: | carbamazepine |
| Active Ingredient(s): | 300 mg/1 & nbsp; carbamazepine |
| Administration Route(s): | ORAL |
| Dosage Form(s): | CAPSULE, EXTENDED RELEASE |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Equetro
| Product NDC: | 30698-423 |
| Labeler Name: | Validus Pharmaceuticals LLC |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA021710 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20041210 |
Package Information of Equetro
| Package NDC: | 30698-423-12 |
| Package Description: | 120 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (30698-423-12) |
NDC Information of Equetro
| NDC Code | 30698-423-12 |
| Proprietary Name | Equetro |
| Package Description | 120 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (30698-423-12) |
| Product NDC | 30698-423 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | carbamazepine |
| Dosage Form Name | CAPSULE, EXTENDED RELEASE |
| Route Name | ORAL |
| Start Marketing Date | 20041210 |
| Marketing Category Name | NDA |
| Labeler Name | Validus Pharmaceuticals LLC |
| Substance Name | CARBAMAZEPINE |
| Strength Number | 300 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE],Mood Stabilizer [EPC] |
